NAGA Antibody

Product Specifications

Background

NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease) .

NCBI Gene ID

4668

Swiss Prot

P17050

Host

Rabbit

Reactivity

Human, Mouse, Rat

Immunogen

Recombinant fusion protein containing a sequence corresponding to amino acids 312-411 of human NAGA (NP_000253.1) .

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Cancer, Signal Transduction

Purification

Affinity purification

Positive Control

HL-60

Concentration

Batch dependent

Buffer

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Store at -20˚ C. Avoid freeze / thaw cycles.

Calculated Molecular Weight

Observed: 46kDa

Fragment

IgG

Applications Notes

WB: 1:500 - 1:2000

Symbol

NAGA

Positive Control 2

Mouse liver

Positive Control 3

Mouse kidney

Positive Control 4

Mouse lung

Positive Control 5

Rat testis

NCBI Official Name

Alpha-N-acetylgalactosaminidase

NCBI Organism

Homo sapiens

Other Product Names

D22S674, GALB, alpha-N-acetylgalactosaminidase, Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B), N-acetylgalactosaminidase, alpha-, alpha-galactosidase B